Calamos Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Calamos Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,619	Closed	-$563K	–	1015
2026 Q1	$563K	Sell	14,619 -11,401	-44%	-$470K	﹤0.01%	894
2025 Q4	$1.07M	Buy	26,020 +10,135	+64%	+$400K	﹤0.01%	679
2025 Q3	$591K	Buy	15,885 +10,121	+176%	+$368K	﹤0.01%	755
2025 Q2	$210K	Sell	5,764 -726	-11%	-$26.3K	﹤0.01%	820
2025 Q1	$251K	Buy	+6,490	New	+$257K	﹤0.01%	784
2024 Q4	–	Sell	-5,188	Closed	-$218K	–	916
2024 Q3	$218K	Sell	5,188 -2,696	-34%	-$112K	﹤0.01%	786
2024 Q2	$322K	Buy	7,884 +2,500	+46%	+$99.5K	﹤0.01%	739
2024 Q1	$223K	Buy	+5,384	New	+$225K	﹤0.01%	764

Other funds holding BME

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

ACM

Alessandra Capital Management Torrance, California $141M AUM

SAM

Smith Asset Management Chiefland, Florida $127M AUM 5.85% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

PFO

PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return

Calamos Advisors's BME Position: Q2 2026 in Review

Calamos Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2026, closing a stake of 14,619 shares — an estimated $563K sold.

Calamos Advisors first reported a position in BME in Q1 2024 and held it in 8 quarters. The position peaked at $1.07M in Q4 2025. 31 funds tracked by Wall St. Rank hold BME as of Q2 2026.

Calamos Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 14,619 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $563K.
Calamos Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2024 and held it in 8 quarters.
Calamos Advisors's BlackRock Health Sciences Trust position peaked at $1.07M in Q4 2025.
31 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.